中国临床药理学杂志2018，Vol.34Issue(19)：2359-2361,2365,4.DOI:10.13699/j.cnki.1001-6821.2018.19.023
血友病治疗的研究现状
Research status of hemophilia treatment
季双敏 1冀希炜 2于爱平 1高晨燕1
作者信息
- 1. 国家食品药品监督管理总局 药品审评中心,北京 100022
- 2. 北京大学 第一医院 临床药理研究所,北京100191
- 折叠
摘要
Abstract
Hemophilia is genetic bleeding disorder , and the replacement therapy by the infusion coagulation factors provides an available effective for hemophilia.With the drug development at home and abroad , signifi-cant progress has been achieved in the field of hemophilia treatment in recent years, including the design of long -acting clotting factor prepara-tions, gene therapy, and novel agents.This study provides a brief over-view of current therapies for hemophilia and reviews the latest develop-ments in its treatment.关键词
血友病/凝血因子/基因治疗/进展Key words
hemophilia/coagulation factor/gene therapy/progress分类
医药卫生引用本文复制引用
季双敏,冀希炜,于爱平,高晨燕..血友病治疗的研究现状[J].中国临床药理学杂志,2018,34(19):2359-2361,2365,4.
